日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphoma

CD19靶向嵌合抗原受体T细胞疗法治疗中枢神经系统淋巴瘤失败的模式、危险因素及管理

Kaulen, Leon D; Karschnia, Philipp; Doubrovinskaia, Sofia; Abramson, Jeremy S; Soumerai, Jacob D; Martinez-Lage, Maria; Haydu, J Erika; Shankar, Ganesh M; Patel, Chirayu; Choi, Bryan D; Barnes, Jeffrey A; El-Jawahri, Areej; Hochberg, Ephraim P; Johnson, P Connor; Wick, Wolfgang; Maus, Marcela V; Chen, Yi-Bin; Frigault, Matthew J; Dietrich, Jorg

Prognostic value of serological and PET/CT response kinetics in patients with multiple myeloma treated with BCMA CAR-T

血清学和PET/CT反应动力学在接受BCMA CAR-T治疗的多发性骨髓瘤患者中的预后价值

Gustine, Joshua N; Scaringi, John A; Bauer, Fabian; Cirstea, Diana D; Branagan, Andrew R; Puliafito, Benjamin R; Maus, Marcela V; Frigault, Matthew J; Yee, Andrew J; Mahmood, Umar; Raje, Noopur S

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

利索卡巴吉内马拉鲁塞输注后2周以上发生细胞因子释放综合征(CRS)或免疫复合物相关神经病变(ICANS)的情况很少见:来自临床试验和真实世界的数据

Hunter, Bradley D; Lunning, Matthew; Shadman, Mazyar; Ahmed, Sairah; Abramson, Jeremy S; Perales, Miguel-Angel; Ahmed, Nausheen; Mirza, Abu-Sayeef; Isufi, Iris; Frigault, Matthew J; Crombie, Jennifer L; Miklos, David B; Vasconcelos, Alberto; Crotta, Alessandro; Bernasconi, David; Roy, Debasmita; Bleickardt, Eric; Pasquini, Marcelo C; Kamdar, Manali

Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma

Enitociclib (VIP152)、venetoclax 和泼尼松治疗复发或难治性侵袭性非霍奇金淋巴瘤

Gordon, Max J; Lakhotia, Rahul; Pittaluga, Stefania; Pack, Svetlana D; Juanitez, Anna Marie; Hamdy, Ahmed; Johnson, Amy J; Frigault, Melanie M; Izumi, Raquel; Raffeld, Mark; Roschewski, Mark; Wilson, Wyndham H; Melani, Christopher

Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment

环磷酰胺可减轻ciltacabtagene autoleucel治疗后出现的非ICANS神经毒性

Blumenberg, Viktoria; Puliafito, Benjamin R; Graham, Charlotte E; Leick, Mark B; Chowdhury, Md Raihan; King, Maxx; Harris, Deshea L; Raje, Noopur S; Branagan, Andrew R; Yee, Andrew J; Cirstea, Diana; Gallagher, Kathleen M E; Dietrich, Jörg; Maus, Marcela V; Frigault, Matthew J

International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma

国际骨髓瘤工作组免疫治疗委员会关于多发性骨髓瘤治疗免疫疗法顺序的建议

Costa, Luciano J; Banerjee, Rahul; Mian, Hira; Weisel, Katja; Bal, Susan; Derman, Benjamin A; Htut, Maung M; Nagarajan, Chandramouli; Rodriguez, Cesar; Richter, Joshua; Frigault, Matthew J; Ye, Jing C; van de Donk, Niels W C J; Voorhees, Peter M; Puliafito, Benjamin; Bahlis, Nizar; Popat, Rakesh; Chng, Wee Joo; Ho, P Joy; Kaur, Gurbakhash; Kapoor, Prashant; Du, Juan; Schjesvold, Fredrik; Berdeja, Jesus; Einsele, Hermann; Cohen, Adam D; Mikhael, Joseph; Biru, Yelak; Rajkumar, S Vincent; Lin, Yi; Martin, Thomas G; Chari, Ajai

Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells.

间皮素是人类脑膜瘤表面存在的一种抗原,可作为 CAR T 细胞的有效靶点。

Ramapriyan Rishab, Barker Fred G 2nd, Richardson Leland G, Sun Jing, Vandecandelaere Gust, Shim Jane M, De Vlaminck Guillaume, Gaffey Matthew, Grewal Eric P, Tazhibi Masih, Morshedy Kourosh, Aref Amir R, Batool Syeda M, Guo Xiaopeng, Ijad Nazanin, Balaj Leonora, Wakimoto Hiroaki, Martinez-Lage Maria, Frigault Matthew J, Leick Mark B, Bernstock Joshua D, Bi Wenya Linda, Carter Bob S, Chiocca E Antonio, Dietrich Jorg, Gerstner Elizabeth R, Boland Genevieve M, Nahed Brian V, Plotkin Scott R, Jenkins Russell W, Brastianos Priscilla K, Curry William T, Maus Marcela V, Choi Bryan D

Association of CD19(+)-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality

CD19(+)靶向嵌合抗原受体(CAR)T细胞疗法与低丙种球蛋白血症、感染和死亡率的关联

Sutherland, Natalia M; Zhou, Baijun; Zhang, Lingxiao; Ong, Mei-Sing; Hong, Joseph S; Pak, Andrew; Liu, Katherine J; Frigault, Matthew J; Maus, Marcela V; Hill, Joshua A; Reynolds, Kerry; Walter, Jolan E; Camargo, Carlos A Jr; Barmettler, Sara

Real-world outcomes with tisagenlecleucel in aggressive B-cell lymphoma: subgroup analyses from the CIBMTR registry

tisagenlecleucel治疗侵袭性B细胞淋巴瘤的真实世界疗效:来自CIBMTR注册研究的亚组分析

Landsburg, Daniel J; Frigault, Matthew J; Heim, Michael; Foley, Stephen Ronan; Hill, Brian; Schofield, Grant; Jacobson, Caron A; Jaglowski, Samantha; Locke, Frederick L; Ram, Ron; Riedell, Peter A; Shah, Gunjan; Popplewell, Leslie L; Tiwari, Ranjan; Lim, Stephen; Majdan, Marta; Masood, Aisha; Pasquini, Marcelo; Turtle, Cameron J

CAR-T cell therapy in older adults with relapsed/refractory LBCL: benefits and challenges

CAR-T细胞疗法在老年复发/难治性大B细胞淋巴瘤患者中的应用:益处与挑战

Shune, Leyla; Frigault, Matthew J; Riedell, Peter A